The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.

Ipratropium bromide nasal solution (nasal spray), 0.03% gives symptomatic relief in cases associated with allergic and ...

A meeting of the board of directors of the company is scheduled to be held on February 11, 2025, to consider and approve the ...

The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.DozQrLpG.js ...

Grasim Industries, the flagship entity of the Aditya Birla Group, posted a consolidated net loss of ₹ 168.7 crore for Q3 FY25 ...

Nasal irrigation can be a useful addition to the management of chronic upper respiratory conditions, including nasal ...

KeyMed Biosciences (HKEX: 02162) today announced the National Medical Products Administration (the "NMPA") of China has recently approved the supplemental New Drug Application (the "sNDA") of ...

A mother wants to respect her 2½-year-old’s preference for dressing like his older sister, but she worries that letting him do so would bother the bridal couple.

Investors interested in arranging a meeting with the Company’s management during the conference can register on the BIO CEO & Investor Conference website here.

This is the year to be optimistic about Alzheimer’s disease says one of Australia’s leading dementia researchers.

Discover the advantages of needle-free vaccines and which companies are developing their own promising delivery solutions in ...